Deadly drug 100 times more potent than fentanyl, as CDC warns of overdose spike
The rise of deadly drugs like carfentanil has become a major concern for public health officials. While fentanyl has long been in the spotlight for driving overdose deaths, the Centers for Disease Control and Prevention (CDC) is now warning of the increasing prevalence of illegally manufactured fentanyls (IMFs), with carfentanil being one of the most potent and dangerous variants.
According to the CDC, nearly 70% of all U.S. overdose deaths last year were attributed to IMFs, with carfentanil leading to a staggering increase in fatal overdoses. The drug, which is an altered version of fentanyl and said to be 100 times more potent, has seen a more than 700% rise in deaths in the past year alone.
The CDC’s State Unintentional Drug Overdose Reporting System (SUDORS) has been instrumental in tracking the alarming trend of carfentanil-related deaths. However, the agency warns that the actual numbers could be even higher, as not all overdose deaths have been reported.
Dr. Chris Tuell, clinical director of addiction services at the University of Cincinnati College of Medicine, shed light on the dangers of carfentanil. He explained that the drug’s high potency and profitability make it an attractive option for illicit drug manufacturers. Even small amounts of carfentanil can be fatal, leading to respiratory failure and accidental overdoses when mixed with other drugs.
Tuell emphasized the importance of educating parents and children about the risks of synthetic opioids like carfentanil. Open communication, monitoring, and supervision are key in protecting children from the dangers of illicit drugs posing as prescription medications. Seeking mental health services for children with substance use disorders can also address underlying issues that may have led to addiction.
In light of the rise in carfentanil-related deaths, the CDC is calling for rigorous monitoring of the drug and other opioids more potent than fentanyl. Efforts to prevent deaths from IMFs include improving risk reduction tools, increasing access to treatment for substance use disorders, and preventing drug use initiation.
As the public health crisis continues to escalate, it is crucial for parents, educators, and healthcare professionals to remain vigilant and proactive in addressing the dangers of deadly opioids like carfentanil. By staying informed and taking necessary precautions, we can work together to combat the devastating impact of these drugs on our communities.
